210 related articles for article (PubMed ID: 33723306)
1. Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression.
Kase Y; Uzawa K; Wagai S; Yoshimura S; Yamamoto JI; Toeda Y; Okubo M; Eizuka K; Ando T; Nobuchi T; Kawasaki K; Saito T; Iyoda M; Nakashima D; Kasamatsu A; Tanzawa H
Sci Rep; 2021 Mar; 11(1):5897. PubMed ID: 33723306
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.
Li YY; Tao YW; Gao S; Li P; Zheng JM; Zhang SE; Liang J; Zhang Y
EBioMedicine; 2018 Oct; 36():209-220. PubMed ID: 30243489
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
[TBL] [Abstract][Full Text] [Related]
5. SARI inhibits growth and reduces survival of oral squamous cell carcinomas (OSCC) by inducing endoplasmic reticulum stress.
Priyadarshini M; Maji S; Samal SK; Rath R; Li J; Das SK; Emdad L; Kundu CN; Fisher PB; Dash R
Life Sci; 2021 Dec; 287():120141. PubMed ID: 34774620
[TBL] [Abstract][Full Text] [Related]
6. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
[TBL] [Abstract][Full Text] [Related]
7. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.
Sayyed AA; Gondaliya P; Mali M; Pawar A; Bhat P; Khairnar A; Arya N; Kalia K
Mol Pharm; 2021 Aug; 18(8):3010-3025. PubMed ID: 34176265
[TBL] [Abstract][Full Text] [Related]
8. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.
Sento S; Sasabe E; Yamamoto T
PLoS One; 2016; 11(2):e0148454. PubMed ID: 26849680
[TBL] [Abstract][Full Text] [Related]
9. Cancer‑associated fibroblast‑derived exosomal miR‑382‑5p promotes the migration and invasion of oral squamous cell carcinoma.
Sun LP; Xu K; Cui J; Yuan DY; Zou B; Li J; Liu JL; Li KY; Meng Z; Zhang B
Oncol Rep; 2019 Oct; 42(4):1319-1328. PubMed ID: 31364748
[TBL] [Abstract][Full Text] [Related]
10. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
11. Analysis of mRNA-miRNA interaction network reveals the role of CAFs-derived exosomes in the immune regulation of oral squamous cell carcinoma.
Wang WZ; Cao X; Bian L; Gao Y; Yu M; Li YT; Xu JG; Wang YH; Yang HF; You DY; He YW
BMC Cancer; 2023 Jun; 23(1):591. PubMed ID: 37365497
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
Chen H; Sa G; Li L; He S; Wu T
Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
[TBL] [Abstract][Full Text] [Related]
13. Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients.
Kuo CS; Yang CY; Lin CK; Lin GJ; Sytwu HK; Chen YW
Biomed Pharmacother; 2021 Jan; 133():111057. PubMed ID: 33378962
[TBL] [Abstract][Full Text] [Related]
14. HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis.
Li W; Zhu Q; Zhang S; Liu L; Zhang H; Zhu D
Oral Oncol; 2020 Dec; 111():104946. PubMed ID: 32763778
[TBL] [Abstract][Full Text] [Related]
15. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
16. MMP-9 Knockdown Inhibits Oral Squamous Cell Carcinoma Lymph Node Metastasis in the Nude Mouse Tongue-Xenografted Model through the RhoC/Src Pathway.
Yin P; Su Y; Chen S; Wen J; Gao F; Wu Y; Zhang X
Anal Cell Pathol (Amst); 2021; 2021():6683391. PubMed ID: 33828938
[TBL] [Abstract][Full Text] [Related]
17. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
Peng QS; Cheng YN; Zhang WB; Fan H; Mao QH; Xu P
Cell Death Dis; 2020 Feb; 11(2):112. PubMed ID: 32041942
[TBL] [Abstract][Full Text] [Related]
18. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
Cai J; Qiao B; Gao N; Lin N; He W
Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
[TBL] [Abstract][Full Text] [Related]
19. The serum biomarker chemerin promotes tumorigenesis and metastasis in oral squamous cell carcinoma.
Lu Z; Liang J; He Q; Wan Q; Hou J; Lian K; Wang A
Clin Sci (Lond); 2019 Mar; 133(5):681-695. PubMed ID: 30804218
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
